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Volume 51, Number 11S Abstracts 99SMultivariate analysis indicated that tissue loss (Rutherford
class 5 and 6) at presentation in the HR group was associ-
ated with decreased limb-salvage (p  0.027).
Conclusions: AIFOD can be treated using HR with
similar short and long-term efficacy as OR. HR should be
considered for all patients with AIFOD, particularly those
with high surgical risk. Tissue loss at presentation is associ-
ated with an increased risk of amputation in patients under-
going HR.
Author Disclosures: T. C. Bower: Nothing to disclose; S.
Cha: Nothing to disclose; A. A. Duncan: Nothing to
disclose; P. Gloviczki: Nothing to disclose; M. Kalra:
Nothing to disclose; G. S. Oderich: Nothing to disclose;
M. Piazza: Nothing to disclose; J. J. Ricotta: Nothing to
disclose.
RR26.
Longitudinal Outcomes After Tibioperoneal Angio-
plasty in the US Medicare Population: In-hospital and
30-Day Outcomes
Todd R. Vogel1, Viktor Y. Dombro vs kiy1, Jeffrey L.
Carson2, Alan M. Graham1. 1Department of Surgery,
UMDNJ-Robert Wood Johnson Medical School, New
Brunswick, NJ; 2UMDNJ-Robert Wood Johnson Medical
School - Department of Medicine, New Brunswick, NJ
Objectives: Catheter-based revascularization has
emerged as an alternative to surgical bypass for the tibio-
peroneal vessels. Most studies are from single centers and
are not population based.
Methods: We identified patients undergoing tibio-
peroneal angioplasty using The Centers for Medicare &
Medicaid Services inpatient claims for 2007. We assessed
in-hospital complications, mortality, 30-day secondary pro-
cedures, and 30-day readmissions after discharge.
Results: We identified 9, 560 subjects undergoing tibio-
peroneal angioplasty (53.5%male; 77.2%White, 16.0%Black)
and 32.3% had a stent, 48.8% had femoral-popliteal angio-
plasty, and 20.5% had atherectomy during their initial proce-
dure. Initial hospital complications included: acute renal fail-
ure (7.3%), acute respiratory failure (5.1%), and acute cardiac
arrest or infarction (3.1%).Mortality in-hospital was 2.2% and
at 30-days was 5.2%. 30-day readmission rate was 29.4%.
30-day reinterventions included: repeat angiogram (9.1%),
repeat angioplasty (7.5%), open bypass (1.4%), and lower
extremity amputations (15.8%). Infection/gangrene was the
most frequent diagnosis at readmission (16.4%). Predictors of
30-day readmission included: Black race (OR 1.2; 95% CI:
1.1-1.3), congestive heart failure (OR  1.5; 95% CI: 1.3-
1.6), and chronic renal failure (OR  1.8; 95% CI:
1.6-2.0).
Conclusions: Tibioperoneal angioplasty is associated
with frequent life threatening in-hospital complications and
a 30-day readmission rate of almost 30%. Infection and
gangrene lead to amputation in more than 15% of patients
after their initial angioplasty procedure within 30 days. Fur-ther detailed analysis of tibioperoneal intervention is essential
as early amputation may be justified in certain cohorts to
decrease the high complication and readmission rates.
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Objectives: To evaluate the effect of physician vol-
ume/specialty and hospital volume on population-level
outcomes from endovascular repair for aortoiliac occlusive
disease (AIOD).
Methods: This is a retrospective cross-sectional analy-
sis of all patients who underwent endovascular repair for
AIOD in the HCUP-NIS, 2003-7. Physicians were low-
(17 procedures/yr, or50th percentile) or high-volume
(17 procedures/yr). Physicians were defined as surgeons
if they had performed 1 carotid/aortic/iliac endarterec-
tomy, open aortic repair, above/below knee amputation,
or aortoiliac-femoral bypass. Hospital volume was low
(116 procedures/yr, or50th percentile) or high (116
procedures/yr). These provider variables, along with other
patient demographic and clinical characteristics, were asso-
ciated with in-hospital complications and mortality, LOS,
and cost using bivariate and multivariate analyses.
Results: 818 patients with AIOD were identified. 59%
of high-volume physicians were surgeons, of which 65%
practiced at high-volume hospitals. Unadjusted complica-
tion rates were significantly higher for low- compared to
high-volume physicians (19 vs 13%, respectively, p 0.05);
they were not different by physician specialty or hospital
volume. Mortality tended to be lower for high-volume
physicians and hospitals. Shorter LOS was associated with
physician volume and specialty, as well as hospital volume,
while decreased cost was associated with physician specialty
(all p  0.05). On multivariate analysis, high physician
volume was associated with significantly lower complica-
tion rates, high hospital volume with shorter LOS, and
non-surgeons with higher costs (all p  0.05).
Conclusions: Overall, volume at both the physician
and hospital level appears to be a robust predictor of patient
outcomes following endovascular interventions for AIOD.
Physician volume, not specialty, is a significant predictor of
complications, even after case-mix adjustment.
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